A study to evaluate the amount of drug that becomes available to the blood circulation when inhaled by a nebulizer and dry powder inhaler in healthy subjects.

Trial Identifier:	D3742C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT04072562
Start Date:	September 2019
Primary Completion Date:	November 2019
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.